In summary, we have identified a requirement for the TIAM1-RAC1 signaling module for SCLC survival and highlighted the TIAM1-Nur77 interaction as well as TIAM1-mediated RAC1 activation as potential therapeutic targets. This evidence concerns the gene NR4A1 and small cell lung carcinoma.